227 related articles for article (PubMed ID: 37693353)
1. Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.
He Y; Li R; Yin J; Yang Z; Wang Y; Chen L; Yang S; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1204623. PubMed ID: 37693353
[TBL] [Abstract][Full Text] [Related]
2. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
3. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
4. Comparison of IVF/ICSI outcomes in advanced reproductive age patients with polycystic ovary syndrome and advanced reproductive age normal controls: a retrospective cohort study.
Zhang X; Lian F; Liu D
BMC Pregnancy Childbirth; 2023 Jun; 23(1):440. PubMed ID: 37316805
[TBL] [Abstract][Full Text] [Related]
5. Effect of basal luteinizing hormone (bLH) level on in vitro fertilization/intra-cytoplasmic injections (IVF/ICSI) outcomes in polycystic ovarian syndrome (PCOS) patients.
Liu Z; Wang KH
BMC Pregnancy Childbirth; 2023 Aug; 23(1):618. PubMed ID: 37644399
[TBL] [Abstract][Full Text] [Related]
6. Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Yuwen T; Yang Z; Cai G; Feng G; Liu Q; Fu H
Reprod Biol Endocrinol; 2023 Oct; 21(1):95. PubMed ID: 37872575
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.
Liu X; Han Y; Wang X; Zhang Y; Du A; Yao R; Lv J; Luo H
BMC Pregnancy Childbirth; 2022 Apr; 22(1):279. PubMed ID: 35366830
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles.
Mai Z; Liu M; Pan P; Li L; Huang J; Chen X; Yang D
Front Endocrinol (Lausanne); 2021; 12():724333. PubMed ID: 34650517
[TBL] [Abstract][Full Text] [Related]
9. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
[TBL] [Abstract][Full Text] [Related]
10. The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy.
Dou Q; Ma LY; Li PF; Xu XT; Yu G; Zhang D; Xiang YG; Tan L
Sci Rep; 2023 Apr; 13(1):5978. PubMed ID: 37045897
[TBL] [Abstract][Full Text] [Related]
11. Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET.
Zhou H; Zhang D; Luo Z; Yang A; Cui N; Hao G; Wang W
Biomed Res Int; 2020; 2020():6434080. PubMed ID: 32908902
[TBL] [Abstract][Full Text] [Related]
12. Association between body mass index and in vitro fertilization/intra-cytoplasmic sperm injection outcomes: An analysis of 15,124 normal ovarian responders in China.
Zheng D; Wang Y; Chen L; Zeng L; Li R
Chin Med J (Engl); 2024 Apr; 137(7):837-845. PubMed ID: 38494342
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting cumulative live birth rate after the 1st oocyte retrieved in polycystic ovary syndrome patients in women during IVF/ICSI-ET.
Li Y; Xia L; Li Z; Zhang Z; Jiang R
J Ovarian Res; 2023 Oct; 16(1):201. PubMed ID: 37833722
[TBL] [Abstract][Full Text] [Related]
14. Impact of polycystic ovary syndrome on selected indicators of in vitro fertilization and intracytoplasmic sperm injection treatment success.
Beydoun HA; Stadtmauer L; Zhao Y; Russell H; Matson DO; Oehninger S
J Womens Health (Larchmt); 2009 May; 18(5):717-23. PubMed ID: 19368509
[TBL] [Abstract][Full Text] [Related]
15. [Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].
Jiang LL; Pan P; Jiao XD; Qiu Q; Li Y; Zhang QX
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1042-1048. PubMed ID: 37032154
[No Abstract] [Full Text] [Related]
16. Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.
Wu Y; Yang R; Lan J; Lin H; Jiao X; Zhang Q
Front Endocrinol (Lausanne); 2021; 12():739228. PubMed ID: 34880831
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
[TBL] [Abstract][Full Text] [Related]
18. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
19. Serum steroid metabolome on the day of oocyte retrieval in women with polycystic ovarian syndrome and its association with pregnancy outcome of in vitro fertilization.
Zhu K; Chen Y; Sang Y; Chen Q; Wang G; Zhu B; Lin T; Mao L; Zhu Y
J Steroid Biochem Mol Biol; 2023 Jul; 231():106311. PubMed ID: 37060931
[TBL] [Abstract][Full Text] [Related]
20. Impact of Thyroid Autoimmunity on
Huang N; Chen L; Lian Y; Wang H; Li R; Qiao J; Chi H
Front Endocrinol (Lausanne); 2021; 12():698579. PubMed ID: 34305818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
